Hodgkin lymphoma (HL) is a curable disease with currently available chemotherapy
regimens. Major late morbidities can potentially be avoided in most limited-stage HL patients …

Abstract Abstract 549 Introduction Early stage classical Hodgkin lymphoma (cHL) is highly
curable with a combination of chemotherapy and radiotherapy (RT). Late toxicities due to RT …

18F-fluorodeoxyglucose positron emission tomography with (FDG-PET) has a well-
established role in the pre-and post-treatment staging of Hodgkin lymphoma (HL), however …

[18F]-Fluoro-2-deoxy-d-glucose positron emission tomography (18F-FDG PET) scan
performed early during the therapy for Hodgkin lymphoma (HL) has a high prognostic value …

PET performed after 2 cycles of chemotherapy (PET2) allows prediction of outcome in most
patients with Hodgkin lymphoma (HL). Visual analysis using a 5-point scale was proposed …

Purpose The use of early (interim) PET restaging during first-line therapy of Hodgkin's
lymphoma (HL) in clinical practice has considerably increased because of its ability to …

Background. Combined modality treatment (CMT) consisting of two cycles of ABVD
(doxorubicin, bleomycin, vinblastine, dacarbazine) and 20 Gy of involved-field radiotherapy …

Despite the rewarding results achieved in the treatment of Hodgkin lymphoma (HL),
concerns have been raised regarding the long-term complications induced by therapy …

Background Hodgkin lymphoma (HL) is one of the most common malignancies in young
adults and one of the most curable cancers worldwide. With interim PET-scan, HL treatment …

Given the excellent survival rates for early-stage Hodgkin lymphoma (HL), the young age of
many patients, and concerns regarding acute and late treatment-related toxicities, there is a …